Novel targets for the treatment of obesity: a review of progress
These medications, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), typically reduce triglycerides by 10-20% and LDL cholesterol by 2-10%
Metabolism slows down as the body tries to conserve energy (NIH)
There is no single winner
Men should just be aware that they are using it off-label, meaning we rely on smaller studies and clinical experience rather than formal FDA-vetted data
The aim of this literature review is to describe and discuss the endocrine and metabolic issues underlying PWS, emphasizing potential genotype-phenotype correlations to assist healthcare professionals in their practice and to guide future research endeavors, in order to provide some benefit to people with the syndrome and their families